Monsanto Co. (NYSE:MON)‘s stock had its “buy” rating reissued by investment analysts at Argus in a research note issued on Sunday. They presently have a $128.00 price target on the stock. Argus’ price objective indicates a potential upside of 23.84% from the stock’s previous close.
A number of other equities analysts also recently commented on the stock. BMO Capital Markets reissued an “outperform” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Saturday. JPMorgan Chase & Co. set a $128.00 price objective on shares of Monsanto and gave the stock a “buy” rating in a research note on Thursday. Zacks Investment Research downgraded shares of Monsanto from a “hold” rating to a “strong sell” rating in a research note on Friday. Deutsche Bank AG reissued a “buy” rating on shares of Monsanto in a research note on Thursday. Finally, Barclays PLC reissued a “hold” rating and issued a $110.00 price objective on shares of Monsanto in a research note on Thursday. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Monsanto currently has a consensus rating of “Buy” and a consensus target price of $114.67.
Monsanto (NYSE:MON) opened at 103.36 on Friday. The stock has a market capitalization of $45.23 billion, a P/E ratio of 45.49 and a beta of 1.19. The stock has a 50 day moving average price of $104.86 and a 200-day moving average price of $101.43. Monsanto has a 1-year low of $83.73 and a 1-year high of $114.26.
Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. Monsanto’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.19) earnings per share. Equities research analysts expect that Monsanto will post $4.89 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 2.09%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio is presently 71.05%.
In other Monsanto news, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction dated Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the sale, the chief executive officer now owns 21,583 shares in the company, valued at approximately $2,196,501.91. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction dated Thursday, July 14th. The shares were sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the completion of the sale, the chief operating officer now owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.
Hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in Monsanto by 1.3% in the second quarter. Vanguard Group Inc. now owns 30,430,570 shares of the company’s stock worth $3,146,826,000 after buying an additional 389,914 shares during the last quarter. State Street Corp increased its stake in Monsanto by 0.9% in the first quarter. State Street Corp now owns 18,623,044 shares of the company’s stock worth $1,634,002,000 after buying an additional 173,201 shares during the last quarter. FMR LLC increased its stake in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock worth $1,540,185,000 after buying an additional 38,316 shares during the last quarter. Finally, Capital International Investors increased its stake in Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock worth $846,690,000 after buying an additional 476,848 shares during the last quarter. Institutional investors own 79.02% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.